Tvardi Therapeutics, Inc. (NASDAQ:TVRD) filed a Form 8-K with the Securities and Exchange Commission on January 16, 2026, disclosing a material event.
Tvardi Therapeutics, Inc.'s stock currently trades at $4.57 with a market capitalization of $42,122,235. The Healthcare company's stock moved following the disclosure.